Novavax Announces Successful H7N9 Trials

Novavax announced on July 29 a positive preclinical trial for its virus-like particle vaccine candidate against the H7N9 Influenza A, which protected 100 percent of the mice studied in the trial from infection.

The data from the study was published in the journal Vaccine. Researchers in the study used three control groups to test the efficacy of the new vaccine candidate; the control groups used a VLP vaccine against H7N3, a VLP vaccine against H5N1 and a placebo. Some of the immunizations also contained Isomatrix, an adjuvant based on saponin.

Researchers from the study conducted the preclinical trial based on a mouse model. During the study, researchers saw an increase in the hemagglutination-inhibition antibody response towards H7N9.

via Novavax announced positive preclinical trial for H7N9 influenza vaccine | Vaccine News Daily.


TLS Detox Kit

TLS Detox Kit What Makes the TLS® Detox Kit Unique?The TLS Detox Kit combines four of our most popular products to support your health, wellness and weight loss. Shed pounds and bodily waste with the TLS Detox kit and save over 28%!The NutriClean® System &md... See details

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: